IngentaConnect Influence of a single dose of 20mg tadalafil, a phosphodiesterase...

Authors: Patterson, Dean; McInnes, Gordon T.¹; Webster, John²; Mitchell, Malcolm M.³; MacDonald, Thomas M.⁴

Source: British Journal of Clinical Pharmacology, Volume 62, Number 3, September 2006 , pp. 280-287(8)

Abstract:

Aims

To test the non-inferiority of a single dose of tadalafil 20 mg compared with placebo with respect to 26-h mean ambulatory systolic and diastolic blood pressure in treated and untreated hypertensive subjects. Methods

A multicentre, randomized, double-blind, placebo-controlled crossover study in 114 subjects with hypertension (36 subjects on no therapy with daytime mean ambulatory blood pressure ≥ 140/85 mmHg; 38 subjects on two to four classes of antihypertensive agents with daytime mean ambulatory blood pressure ≥140/85 mmHg and 40 subjects on two to four classes of antihypertensive agents with ambulatory blood pressure < 140/85 mmHg). Results

Overall tadalafil reduced mean ambulatory blood pressure monitor systolic and diastolic blood pressure by 4.8 mmHg [95% confidence interval (Cl) 3.7, 5.9; P < 0.01] and 2.9 mmHg (95% CI 1.9, 3.6; P < 0.01), respectively, compared with placebo. In hypertensive subjects with uncontrolled blood pressure on two to four classes of antihypertensive agents (n = 36) tadalafil reduced mean ABPM systolic and diastolic blood pressure by 7.5 mmHg (95% CI 5.4, 9.6; P < 0.01) and 4.3 mmHg (95% CI 6.1, 8.9; P < 0.01) compared with placebo. Conclusions

In patients with uncontrolled hypertension on multiple agents the addition of tadalafil 20 mg lowered mean 26-h blood pressure.

Keywords: ambulatory blood pressure; hypertension; phosphodiesterase-5 inhibitor

Document Type: Research article

DOI: 10.1111/j.1365-2125.2006.02658.x

Affiliations: 1: Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, 2: Clinical Pharmacology Unit, Aberdeen Royal Infirmary, Aberdeen and 3: Eli-Lilly, Windlesham, UK 4: Department of Medicine, Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, Dundee, UK,

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on Synergy.

You may be required to register and activate access on Synergy before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Influence of a single dose of 20 mg tadalafil, a phosphodiesterase 5 inhibitor, on ambulatory blood pressure in subjects with hypertension